Evidence map›Paper›PMID 31090680›Full record

ReviewShock (Augusta, Ga.)2020

Resuscitative Strategies to Modulate the Endotheliopathy of Trauma: From Cell to Patient.

Feng Wu, Amanda Chipman, Shibani Pati, Byron Miyasawa, Laurence Corash, Rosemary A Kozar

Open access · greenAbstract readReview
In one paragraph

Review in Shock (Augusta, Ga.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Rethinking Balanced Resuscitation in Trauma.Journal of clinical medicine · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Prehospital Plasma Transfusion: What Does the Literature Show?Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Feng WuShock Trauma Center, University of Maryland School of Medicine, Baltimore, Maryland.
Amanda ChipmanDepartment of Surgery, University of Maryland School of Medicine, Baltimore, Maryland.
Shibani PatiDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, California.
Byron MiyasawaDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, California.
Laurence CorashDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, California.
Rosemary A KozarShock Trauma Center, University of Maryland School of Medicine, Baltimore, Maryland.
University of California, San Francisco · USUniversity of Maryland, Baltimore · US

Funding

Vascular Biology Training ProgramT32HL007698 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI Rosemary A Kozar, Dudley K. Strickland · 1991 to 2026
$8.7M
Endothelial injury and repair following hemorrhagic shockR01GM129533 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI KOZAR, ROSEMARY A · 2018 to 2021
$1.4M
Syndecan shedding after trauma and hemorrhagic shockR01GM107482 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KOZAR, ROSEMARY A · 2013 to 2016
$1.2M
NHLBI NIH HHS T32 HL007698NIGMS NIH HHS R01 GM107482NIGMS NIH HHS R01 GM129533
6 · The paper itself

Abstract

Clinical data has supported the early use of plasma in high ratios of plasma to red cells to patients in hemorrhagic shock. The benefit from plasma seems to extend beyond its hemostatic effects to include protection to the post-shock dysfunctional endothelium. Resuscitation of the endothelium by plasma and one of its major constituents, fibrinogen, involves cell surface stabilization of syndecan-1, a transmembrane proteoglycan and the protein backbone of the endothelial glycocalyx. The pathogenic role of miRNA-19b to the endothelium is explored along with the PAK-1-mediated intracellular pathway that may link syndecan-1 to cytoskeletal protection. Additionally, clinical studies using fibrinogen and cyroprecipitate to aid in hemostasis of the bleeding patient are reviewed and new data to suggest a role for plasma and its byproducts to treat the dysfunctional endothelium associated with nonbleeding diseases is presented.

Indexed as

ResuscitationEndotheliumGlycocalyxHumansShock, HemorrhagicSyndecan-1Wounds and InjuriesSyndecan-1

Identifiers

PMID31090680
PMCPMC6842415
OpenAlexW2945779887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.